Success Story: NIW Approved Through Premium Processing: Our Expert Teams Supported Indian Researcher V in Earning a Successful Outcome
Client’s Testimonial:
“It was indeed a great experience working with the Chen Immigration Attorney team. I have found this firm highly experienced, responsive and efficient in their job. I have applied for EB-2 NIW through premium processing and received a positive outcome in the desired time frame. I highly recommend Chen Attorneys for Immigration related concerns. If you need one, go with the best one.”
On April 2nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher V in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Researcher V
Country of Origin: India
State of Residence at the Time of Filing: Alabama
Approval Notice Date: April 2nd, 2025
Processing Time: 1 month, 28 days (Premium Processing Requested)
Case Summary:
At North America Immigration Law Group, we are pleased to share another successful I-140 NIW (National Interest Waiver) case, this time on behalf of a Ph.D. holder working at the forefront of cancer immunology. Filed under Premium Processing, the petition was approved just 1 month and 28 days later.
Our client is a biomedical scientist specializing in pancreatic cancer, with a focus on the tumor microenvironment and immune modulation. Her proposed endeavor aims to enhance treatment efficacy by developing methods that synergize with immunotherapies and chemotherapies, ultimately improving patient outcomes. At the time of filing, she was conducting research in the U.S. and planned to continue publishing work on cancer immunology in high-impact venues.
To demonstrate her eligibility, we highlighted:
Publications and Citations: She has authored 12 peer-reviewed journal articles, 23 conference abstracts, and 1 book chapter, accumulating 222 citations. At least 4 of her papers ranked in the top 10–20% most cited in immunology for their publication years.
Peer Review Contributions: She completed at least 20 peer reviews for high-ranking journals in the biomedical sciences.
Significance and Impact: Her research has contributed to a better understanding of cancer-associated fibroblasts, tumor immune evasion, and immune checkpoint therapy. Her work has been widely cited by international scholars and supported by U.S. Department of Defense funding, underscoring its national importance.
The petition was further supported by 2 expert letters of recommendation attesting to the impact and novelty of her research.
One recommender remarked:
“[Client] has contributed valuable research for pancreatic cancer immunotherapy. Moreover, she actively maintains high standards of publication through her peer review service for notable journals, which further attests to her sustained leadership in the field. It is thus imperative that her research continue.”
We are honored to have supported this talented scientist and celebrate her swift NIW approval. Her work promises to advance U.S. leadership in cancer research and patient care.

